Computational pathology services platform 3Scan has raised $14 million in Series B financing. The investment was led by existing investors Lux Capital and Data Collective. Other participants in the financing round include the investment arm of a U.S. research hospital, Dolby Family Ventures, OS Fund, Comet Labs, and Breakout Ventures.

Founded in 2010, 3Scan says it uses robotics and computer vision for tissue examination.

[Image courtesy: 3Scan]